| NDC Number | Brand Name | Generic Name | Manufacturer | Dosage Form | DEA Sch. | Marketing Start Date |
|---|---|---|---|---|---|---|
| 0002-2980 | RETEVMO | selpercatinib | Eli Lilly and Company | CAPSULE | 2020-05-08 | |
| 0002-3977 | RETEVMO | selpercatinib | Eli Lilly and Company | CAPSULE | 2020-05-08 | |
| 0002-4182 | Olumiant | baricitinib | Eli Lilly and Company | TABLET, FILM COATED | 2018-05-31 | |
| 0002-4479 | Olumiant | baricitinib | Eli Lilly and Company | TABLET, FILM COATED | 2022-05-10 | |
| 0002-4483 | Verzenio | abemaciclib | Eli Lilly and Company | TABLET | 2017-09-28 | |
| 0002-4732 | Olumiant | baricitinib | Eli Lilly and Company | TABLET, FILM COATED | 2019-10-08 | |
| 0002-4815 | Verzenio | abemaciclib | Eli Lilly and Company | TABLET | 2017-09-28 | |
| 0002-5337 | Verzenio | abemaciclib | Eli Lilly and Company | TABLET | 2017-09-28 | |
| 0002-5340 | RETEVMO | selpercatinib | Eli Lilly and Company | TABLET, COATED | 2024-04-10 | |
| 0002-5562 | RETEVMO | selpercatinib | Eli Lilly and Company | TABLET, COATED | 2024-04-10 | |
| 0002-6082 | RETEVMO | selpercatinib | Eli Lilly and Company | TABLET, COATED | 2024-04-10 | |
| 0002-6120 | RETEVMO | selpercatinib | Eli Lilly and Company | TABLET, COATED | 2024-04-10 | |
| 0002-6216 | Verzenio | abemaciclib | Eli Lilly and Company | TABLET | 2017-09-28 | |
| 0002-6885 | Baricitinib | baricitinib | Eli Lilly and Company | TABLET, FILM COATED | 2021-12-20 | |
| 0002-6902 | JAYPIRCA | pirtobrutinib | Eli Lilly and Company | TABLET, COATED | 2023-01-27 | |
| 0002-7026 | JAYPIRCA | pirtobrutinib | Eli Lilly and Company | TABLET, COATED | 2023-01-27 | |
| 0003-4040 | Augtyro | repotrectinib | E.R. Squibb & Sons, L.L.C. | CAPSULE | 2023-12-05 | |
| 0003-4160 | Augtyro | repotrectinib | E.R. Squibb & Sons, L.L.C. | CAPSULE | 2024-11-01 | |
| 0008-1041 | Rapamune | SIROLIMUS | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | TABLET, SUGAR COATED | 2001-07-01 | |
| 0008-1042 | Rapamune | SIROLIMUS | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | TABLET, SUGAR COATED | 2001-07-01 | |
| 0054-0470 | Everolimus | Everolimus | Hikma Pharmaceuticals USA Inc. | TABLET | 2020-03-10 | |
| 0054-0471 | Everolimus | Everolimus | Hikma Pharmaceuticals USA Inc. | TABLET | 2020-03-10 | |
| 0054-0472 | Everolimus | Everolimus | Hikma Pharmaceuticals USA Inc. | TABLET | 2020-03-10 | |
| 0054-0480 | Everolimus | Everolimus | Hikma Pharmaceuticals USA Inc. | TABLET | 2020-06-08 | |
| 0054-0481 | Everolimus | Everolimus | Hikma Pharmaceuticals USA Inc. | TABLET | 2020-06-08 | |
| 0054-0482 | Everolimus | Everolimus | Hikma Pharmaceuticals USA Inc. | TABLET | 2020-06-08 | |
| 0054-0497 | Everolimus | Everolimus | Hikma Pharmaceuticals USA Inc. | TABLET | 2020-06-08 | |
| 0054-0604 | Everolimus | Everolimus | Hikma Pharmaceuticals USA Inc. | TABLET | 2021-11-18 | |
| 0069-0145 | INLYTA | axitinib | Pfizer Laboratories Div Pfizer Inc | TABLET, FILM COATED | 2012-01-27 | |
| 0069-0151 | INLYTA | axitinib | Pfizer Laboratories Div Pfizer Inc | TABLET, FILM COATED | 2012-01-27 | |
| 0069-0187 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | CAPSULE | 2015-02-03 | |
| 0069-0188 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | CAPSULE | 2015-02-03 | |
| 0069-0189 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | CAPSULE | 2015-02-03 | |
| 0069-0227 | Lorbrena | lorlatinib | Pfizer Laboratories Div Pfizer Inc | TABLET, FILM COATED | 2018-11-19 | |
| 0069-0231 | Lorbrena | lorlatinib | Pfizer Laboratories Div Pfizer Inc | TABLET, FILM COATED | 2018-11-19 | |
| 0069-0235 | Cibinqo | abrocitinib | Pfizer Laboratories Div Pfizer Inc | TABLET, FILM COATED | 2022-02-24 | |
| 0069-0251 | Xalkori | CRIZOTINIB | Pfizer Laboratories Div Pfizer Inc | CAPSULE, COATED PELLETS | 2023-11-20 | |
| 0069-0284 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | TABLET, FILM COATED | 2020-03-30 | |
| 0069-0335 | Cibinqo | abrocitinib | Pfizer Laboratories Div Pfizer Inc | TABLET, FILM COATED | 2022-02-24 | |
| 0069-0435 | Cibinqo | abrocitinib | Pfizer Laboratories Div Pfizer Inc | TABLET, FILM COATED | 2022-02-24 | |
| 0069-0486 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | TABLET, FILM COATED | 2020-03-30 | |
| 0069-0507 | Xalkori | CRIZOTINIB | Pfizer Laboratories Div Pfizer Inc | CAPSULE, COATED PELLETS | 2023-11-20 | |
| 0069-0688 | Ibrance | palbociclib | Pfizer Laboratories Div Pfizer Inc | TABLET, FILM COATED | 2020-03-30 | |
| 0069-1500 | Xalkori | CRIZOTINIB | Pfizer Laboratories Div Pfizer Inc | CAPSULE, COATED PELLETS | 2023-11-20 | |
| 0069-8140 | Xalkori | CRIZOTINIB | Pfizer Laboratories Div Pfizer Inc | CAPSULE | 2011-08-26 | |
| 0069-8141 | Xalkori | CRIZOTINIB | Pfizer Laboratories Div Pfizer Inc | CAPSULE | 2011-08-26 | |
| 0074-1043 | Rinvoq | Upadacitinib | AbbVie Inc. | TABLET, EXTENDED RELEASE | 2019-08-16 | |
| 0074-2306 | Rinvoq | Upadacitinib | AbbVie Inc. | TABLET, EXTENDED RELEASE | 2019-08-16 | |
| 0074-2310 | Rinvoq | Upadacitinib | AbbVie Inc. | TABLET, EXTENDED RELEASE | 2019-08-16 | |
| 0074-2320 | Rinvoq | Upadacitinib | AbbVie Inc. | SOLUTION | 2024-04-26 | |
| 0078-0414 | Zortress | everolimus | Novartis Pharmaceuticals Corporation | TABLET | 2010-04-22 | |
| 0078-0415 | Zortress | everolimus | Novartis Pharmaceuticals Corporation | TABLET | 2010-04-22 | |
| 0078-0417 | Zortress | everolimus | Novartis Pharmaceuticals Corporation | TABLET | 2010-04-22 | |
| 0078-0422 | Zortress | everolimus | Novartis Pharmaceuticals Corporation | TABLET | 2010-04-22 | |
| 0078-0566 | Afinitor | everolimus | Novartis Pharmaceuticals Corporation | TABLET | 2009-03-31 | |
| 0078-0567 | Afinitor | everolimus | Novartis Pharmaceuticals Corporation | TABLET | 2009-03-31 | |
| 0078-0594 | Afinitor | everolimus | Novartis Pharmaceuticals Corporation | TABLET | 2010-07-09 | |
| 0078-0620 | Afinitor | everolimus | Novartis Pharmaceuticals Corporation | TABLET | 2011-07-29 | |
| 0078-0626 | Afinitor Disperz | everolimus | Novartis Pharmaceuticals Corporation | TABLET, FOR SUSPENSION | 2012-08-29 | |
| 0078-0627 | Afinitor Disperz | everolimus | Novartis Pharmaceuticals Corporation | TABLET, FOR SUSPENSION | 2012-08-29 | |
| 0078-0628 | Afinitor Disperz | everolimus | Novartis Pharmaceuticals Corporation | TABLET, FOR SUSPENSION | 2012-08-29 | |
| 0078-0694 | ZYKADIA | ceritinib | Novartis Pharmaceuticals Corporation | TABLET, FILM COATED | 2019-03-18 | |
| 0078-0698 | RYDAPT | RYDAPT | Novartis Pharmaceuticals Corporation | CAPSULE, LIQUID FILLED | 2017-04-28 | |
| 0093-7766 | Everolimus | Everolimus | Teva Pharmaceuticals USA, Inc. | TABLET | 2020-06-10 | |
| 0093-7767 | Everolimus | Everolimus | Teva Pharmaceuticals USA, Inc. | TABLET | 2020-06-10 | |
| 0093-7768 | Everolimus | Everolimus | Teva Pharmaceuticals USA, Inc. | TABLET | 2020-06-10 | |
| 0093-7769 | Everolimus | Everolimus | Teva Pharmaceuticals USA, Inc. | TABLET | 2023-10-23 | |
| 0245-0822 | TORPENZ | Everolimus | Upsher-Smith Laboratories, LLC | TABLET | 2021-10-01 | |
| 0245-0823 | TORPENZ | Everolimus | Upsher-Smith Laboratories, LLC | TABLET | 2021-10-01 | |
| 0245-0824 | TORPENZ | Everolimus | Upsher-Smith Laboratories, LLC | TABLET | 2021-10-01 | |
| 0245-0825 | TORPENZ | Everolimus | Upsher-Smith Laboratories, LLC | TABLET | 2021-10-01 | |
| 0310-0482 | IRESSA | Gefitinib | AstraZeneca Pharmaceuticals LP | TABLET, COATED | 2015-07-13 | |
| 0310-0610 | KOSELUGO | SELUMETINIB | AstraZeneca Pharmaceuticals LP | CAPSULE | 2020-04-16 | |
| 0310-0625 | KOSELUGO | SELUMETINIB | AstraZeneca Pharmaceuticals LP | CAPSULE | 2020-04-16 | |
| 0310-0635 | KOSELUGO | SELUMETINIB | AstraZeneca Pharmaceuticals LP | GRANULE | 2025-09-10 | |
| 0310-0640 | KOSELUGO | SELUMETINIB | AstraZeneca Pharmaceuticals LP | GRANULE | 2025-09-10 | |
| 0310-1248 | TAGRISSO | osimertinib | AstraZeneca Pharmaceuticals LP | TABLET, FILM COATED | 2015-11-13 | |
| 0310-1251 | TAGRISSO | osimertinib | AstraZeneca Pharmaceuticals LP | TABLET, FILM COATED | 2015-11-13 | |
| 0310-1349 | TAGRISSO | osimertinib | AstraZeneca Pharmaceuticals LP | TABLET, FILM COATED | 2015-11-13 | |
| 0310-1350 | TAGRISSO | osimertinib | AstraZeneca Pharmaceuticals LP | TABLET, FILM COATED | 2015-11-13 | |
| 0310-3512 | CALQUENCE | acalabrutinib | AstraZeneca Pharmaceuticals LP | TABLET, FILM COATED | 2022-08-04 | |
| 0310-4513 | CALQUENCE | acalabrutinib | AstraZeneca Pharmaceuticals LP | TABLET, FILM COATED | 2022-08-04 | |
| 0378-0005 | Everolimus | Everolimus | Mylan Pharmaceuticals Inc. | TABLET, FOR SUSPENSION | 2021-10-01 | |
| 0378-0006 | Everolimus | Everolimus | Mylan Pharmaceuticals Inc. | TABLET, FOR SUSPENSION | 2021-10-01 | |
| 0378-0007 | Everolimus | Everolimus | Mylan Pharmaceuticals Inc. | TABLET, FOR SUSPENSION | 2021-10-01 | |
| 0480-4053 | Gefitinib | Gefitinib | Teva Pharmaceuticals, Inc. | TABLET, FILM COATED | 2023-06-21 | |
| 0597-0137 | Gilotrif | afatinib | Boehringer Ingelheim Pharmaceuticals, Inc. | TABLET, FILM COATED | 2013-07-12 | |
| 0597-0138 | Gilotrif | afatinib | Boehringer Ingelheim Pharmaceuticals, Inc. | TABLET, FILM COATED | 2013-07-12 | |
| 0597-0141 | Gilotrif | afatinib | Boehringer Ingelheim Pharmaceuticals, Inc. | TABLET, FILM COATED | 2013-07-12 | |
| 0597-9257 | HERNEXEOS | zongertinib | Boehringer Ingelheim Pharmaceuticals, Inc. | TABLET, FILM COATED | 2025-08-08 | |
| 0904-7248 | Sirolimus | Sirolimus | Major Pharmaceuticals | TABLET | 2021-03-13 | |
| 13668-682 | Sorafenib | sorafenib | Torrent Pharmaceuticals Limited | TABLET, FILM COATED | 2023-04-12 | |
| 16571-806 | Sirolimus | Sirolimus | Rising Pharma Holdings, Inc. | SOLUTION | 2025-07-15 | |
| 16714-187 | sirolimus | sirolimus | NORTHSTAR RX LLC | TABLET, FILM COATED | 2021-10-18 | |
| 16714-188 | sirolimus | sirolimus | NORTHSTAR RX LLC | TABLET, FILM COATED | 2021-10-18 | |
| 16714-189 | sirolimus | sirolimus | NORTHSTAR RX LLC | TABLET, FILM COATED | 2021-10-18 | |
| 24338-154 | DANZITEN | nilotinib | Azurity Pharmaceuticals, Inc. | TABLET | 2024-11-30 | |
| 24338-155 | DANZITEN | nilotinib | Azurity Pharmaceuticals, Inc. | TABLET | 2024-11-30 | |
| 24979-715 | sorafenib | sorafenib | Upsher-Smith Laboratories, LLC | TABLET, FILM COATED | 2022-12-01 | |
| 31722-316 | SIROLIMUS | Sirolimus | Camber Pharmaceuticals, Inc. | SOLUTION | 2024-09-16 | |
| 49884-119 | Everolimus | Everolimus | ENDO USA, Inc. | TABLET | 2019-12-10 | |
| 49884-125 | Everolimus | Everolimus | ENDO USA, Inc. | TABLET | 2019-12-10 | |
| 49884-127 | Everolimus | Everolimus | ENDO USA, Inc. | TABLET | 2019-12-10 | |
| 49884-128 | Everolimus | Everolimus | ENDO USA, Inc. | TABLET | 2022-11-29 | |
| 49884-158 | Everolimus | Everolimus | Par Health USA, LLC | TABLET | 2022-03-31 | |
| 49884-159 | Everolimus | Everolimus | Par Health USA, LLC | TABLET | 2022-03-31 | |
| 49884-160 | Everolimus | Everolimus | Par Health USA, LLC | TABLET | 2022-12-16 | |
| 49884-283 | Everolimus | Everolimus | Par Health USA, LLC | TABLET | 2022-01-26 | |
| 50222-280 | Anzupgo | delgocitinib | LEO Pharma, Inc | CREAM | 2025-07-24 | |
| 50242-079 | Itovebi | Inavolisib | Genentech, Inc. | TABLET, FILM COATED | 2024-10-14 | |
| 50242-084 | Itovebi | Inavolisib | Genentech, Inc. | TABLET, FILM COATED | 2024-10-14 | |
| 50242-090 | ZELBORAF | Vemurafenib | Genentech, Inc. | TABLET, FILM COATED | 2011-08-17 | |
| 50242-210 | Gavreto | Pralsetinib | Genentech, Inc. | CAPSULE | 2021-07-01 | |
| 50268-718 | Sirolimus | Sirolimus | AvPAK | TABLET | 2018-04-23 | |
| 50419-390 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | CAPSULE | 2019-07-26 | |
| 50419-391 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | CAPSULE | 2019-07-26 | |
| 50419-392 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | SOLUTION, CONCENTRATE | 2019-07-26 | |
| 50419-393 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | SOLUTION, CONCENTRATE | 2022-12-06 | |
| 50419-488 | Nexavar | sorafenib | Bayer HealthCare Pharmaceuticals Inc. | TABLET, FILM COATED | 2005-12-20 | |
| 50419-489 | Nexavar | sorafenib | Bayer HealthCare Pharmaceuticals Inc. | TABLET, FILM COATED | 2023-10-02 | |
| 50742-366 | Gefitinib | Gefitinib | Ingenus Pharmaceuticals, LLC | TABLET, COATED | 2023-04-27 | |
| 50881-005 | JAKAFI | ruxolitinib | Incyte Corporation | TABLET | 2011-11-16 | |
| 50881-005 | JAKAFI | ruxolitinib | Incyte Corporation | TABLET | 2011-11-16 | |
| 50881-010 | JAKAFI | ruxolitinib | Incyte Corporation | TABLET | 2011-11-16 | |
| 50881-010 | JAKAFI | ruxolitinib | Incyte Corporation | TABLET | 2011-11-16 | |
| 50881-015 | JAKAFI | ruxolitinib | Incyte Corporation | TABLET | 2011-11-16 | |
| 50881-015 | JAKAFI | ruxolitinib | Incyte Corporation | TABLET | 2011-11-16 | |
| 50881-020 | JAKAFI | ruxolitinib | Incyte Corporation | TABLET | 2011-11-16 | |
| 50881-020 | JAKAFI | ruxolitinib | Incyte Corporation | TABLET | 2011-11-16 | |
| 50881-025 | JAKAFI | ruxolitinib | Incyte Corporation | TABLET | 2011-11-16 | |
| 50881-025 | JAKAFI | ruxolitinib | Incyte Corporation | TABLET | 2011-11-16 | |
| 50881-026 | PEMAZYRE | pemigatinib | Incyte Corporation | TABLET | 2020-04-17 | |
| 50881-027 | PEMAZYRE | pemigatinib | Incyte Corporation | TABLET | 2020-04-17 | |
| 50881-028 | PEMAZYRE | pemigatinib | Incyte Corporation | TABLET | 2020-04-17 | |
| 51144-001 | TUKYSA | tucatinib | SEAGEN INC. | TABLET | 2020-04-17 | |
| 51144-002 | TUKYSA | tucatinib | SEAGEN INC. | TABLET | 2020-04-17 | |
| 51407-760 | sorafenib | sorafenib | Golden State Medical Supply, Inc. | TABLET, FILM COATED | 2022-11-09 | |
| 51407-872 | Pazopanib | Pazopanib | Golden State Medical Supply, Inc. | TABLET | 2023-10-19 | |
| 51990-201 | sorafenib | sorafenib | Yabao Pharmaceutical Co., Ltd. Beijing | TABLET, FILM COATED | 2022-12-01 | |
| 51991-821 | Everolimus | Everolimus | Breckenridge Pharmaceutical, Inc. | TABLET | 2021-03-05 | |
| 51991-822 | Everolimus | Everolimus | Breckenridge Pharmaceutical, Inc. | TABLET | 2021-03-05 | |
| 51991-823 | Everolimus | Everolimus | Breckenridge Pharmaceutical, Inc. | TABLET | 2021-03-05 | |
| 51991-824 | Everolimus | Everolimus | Breckenridge Pharmaceutical, Inc. | TABLET | 2021-03-05 | |
| 51991-990 | Everolimus | Everolimus | Breckenridge Pharmaceutical, Inc. | TABLET, FOR SUSPENSION | 2025-01-28 | |
| 51991-991 | Everolimus | Everolimus | Breckenridge Pharmaceutical, Inc. | TABLET, FOR SUSPENSION | 2025-01-28 | |
| 51991-992 | Everolimus | Everolimus | Breckenridge Pharmaceutical, Inc. | TABLET, FOR SUSPENSION | 2025-01-28 | |
| 55111-653 | Sirolimus | Sirolimus | Dr. Reddy's Laboratories Limited | TABLET | 2014-10-27 | |
| 55111-654 | Sirolimus | Sirolimus | Dr. Reddy's Laboratories Limited | TABLET | 2014-10-27 | |
| 57894-080 | LAZCLUZE | lazertinib | Janssen Biotech, Inc. | TABLET, FILM COATED | 2024-08-20 | |
| 57894-240 | LAZCLUZE | lazertinib | Janssen Biotech, Inc. | TABLET, FILM COATED | 2024-08-20 | |
| 57962-007 | Imbruvica | Ibrutinib | Pharmacyclics LLC | SUSPENSION | 2022-08-24 | |
| 57962-014 | Imbruvica | Ibrutinib | Pharmacyclics LLC | TABLET, FILM COATED | 2018-02-16 | |
| 57962-070 | Imbruvica | Ibrutinib | Pharmacyclics LLC | CAPSULE | 2017-12-20 | |
| 57962-140 | Imbruvica | Ibrutinib | Pharmacyclics LLC | CAPSULE | 2013-11-13 | |
| 57962-280 | Imbruvica | Ibrutinib | Pharmacyclics LLC | TABLET, FILM COATED | 2018-02-16 | |
| 57962-420 | Imbruvica | Ibrutinib | Pharmacyclics LLC | TABLET, FILM COATED | 2018-02-16 | |
| 58468-7820 | CAPRELSA | Vandetanib | Genzyme Corporation | TABLET, FILM COATED | 2011-07-25 | |
| 58468-7840 | CAPRELSA | Vandetanib | Genzyme Corporation | TABLET, FILM COATED | 2011-07-25 | |
| 59676-030 | BALVERSA | Erdafitinib | Janssen Products LP | TABLET, FILM COATED | 2019-04-12 | |
| 59676-040 | BALVERSA | Erdafitinib | Janssen Products LP | TABLET, FILM COATED | 2019-04-12 | |
| 59676-050 | BALVERSA | Erdafitinib | Janssen Products LP | TABLET, FILM COATED | 2019-04-12 | |
| 59762-1001 | Sirolimus | SIROLIMUS | Mylan Pharmaceuticals Inc. | TABLET, SUGAR COATED | 2014-01-07 | |
| 59762-1002 | Sirolimus | SIROLIMUS | Mylan Pharmaceuticals Inc. | TABLET, SUGAR COATED | 2014-10-27 | |
| 59762-1003 | Sirolimus | SIROLIMUS | Mylan Pharmaceuticals Inc. | TABLET, SUGAR COATED | 2014-10-27 | |
| 59762-1205 | Sirolimus | sirolimus | Mylan Pharmaceuticals Inc. | SOLUTION | 2019-07-22 | |
| 60219-2279 | EVEROLIMUS | everolimus | Amneal Pharmaceuticals NY LLC | TABLET, FOR SUSPENSION | 2025-01-14 | |
| 60219-2280 | EVEROLIMUS | everolimus | Amneal Pharmaceuticals NY LLC | TABLET, FOR SUSPENSION | 2025-01-14 | |
| 60219-2281 | EVEROLIMUS | everolimus | Amneal Pharmaceuticals NY LLC | TABLET, FOR SUSPENSION | 2025-01-14 | |
| 60505-3801 | Nilotinib | nilotinib | Apotex Corp. | CAPSULE | 2025-05-23 | |
| 60505-3802 | Nilotinib | nilotinib | Apotex Corp. | CAPSULE | 2025-05-23 | |
| 60505-3803 | Nilotinib | nilotinib | Apotex Corp. | CAPSULE | 2025-05-23 | |
| 60505-4512 | Gefitinib | Gefitinib | Apotex Corp. | TABLET | 2023-08-08 | |
| 60505-4779 | Pazopanib | Pazopanib | Apotex Corp. | TABLET | 2023-10-19 | |
| 60505-6197 | Sirolimus | SIROLIMUS | Apotex Corp | SOLUTION | 2020-05-20 | |
| 61958-1701 | Zydelig | idelalisib | Gilead Sciences, Inc. | TABLET, FILM COATED | 2014-07-23 | |
| 61958-1702 | Zydelig | idelalisib | Gilead Sciences, Inc. | TABLET, FILM COATED | 2014-07-23 | |
| 62856-704 | Lenvima | Lenvatinib | Eisai Inc. | CAPSULE | 2018-08-15 | |
| 62856-708 | Lenvima | Lenvatinib | Eisai Inc. | CAPSULE | 2016-05-13 | |
| 62856-710 | Lenvima | Lenvatinib | Eisai Inc. | CAPSULE | 2015-02-13 | |
| 62856-712 | Lenvima | Lenvatinib | Eisai Inc. | CAPSULE | 2018-08-15 | |
| 62856-714 | Lenvima | Lenvatinib | Eisai Inc. | KIT | 2015-02-13 | |
| 62856-718 | Lenvima | Lenvatinib | Eisai Inc. | KIT | 2016-05-13 | |
| 62856-720 | Lenvima | Lenvatinib | Eisai Inc. | CAPSULE | 2015-02-13 | |
| 62856-724 | Lenvima | Lenvatinib | Eisai Inc. | KIT | 2015-02-13 | |
| 63020-090 | Alunbrig | brigatinib | Takeda Pharmaceuticals America, Inc. | TABLET, FILM COATED | 2017-04-28 | |
| 63020-113 | Alunbrig | brigatinib | Takeda Pharmaceuticals America, Inc. | TABLET, FILM COATED | 2017-04-28 | |
| 63020-180 | Alunbrig | brigatinib | Takeda Pharmaceuticals America, Inc. | TABLET, FILM COATED | 2017-04-28 | |
| 63020-198 | Alunbrig | brigatinib | Takeda Pharmaceuticals America, Inc. | KIT | 2017-04-28 | |
| 63304-095 | Erlotinib | Erlotinib | Sun Pharmaceutical Industries, Inc. | TABLET, FILM COATED | 2019-11-05 | |
| 63304-096 | Erlotinib | Erlotinib | Sun Pharmaceutical Industries, Inc. | TABLET, FILM COATED | 2019-11-05 | |
| 63304-135 | Erlotinib | Erlotinib | Sun Pharmaceutical Industries, Inc. | TABLET, FILM COATED | 2019-11-05 | |
| 63539-026 | INLYTA | axitinib | U.S. Pharmaceuticals | TABLET, FILM COATED | 2012-01-27 | |
| 63539-044 | INLYTA | axitinib | U.S. Pharmaceuticals | TABLET, FILM COATED | 2012-01-27 | |
| 63539-187 | Ibrance | palbociclib | U.S. Pharmaceuticals | CAPSULE | 2017-05-08 | |
| 63539-188 | Ibrance | palbociclib | U.S. Pharmaceuticals | CAPSULE | 2017-05-08 | |
| 63539-189 | Ibrance | palbociclib | U.S. Pharmaceuticals | CAPSULE | 2015-02-03 | |
| 63539-236 | CIBINQO | abrocitinib | U.S. Pharmaceuticals | TABLET, FILM COATED | 2022-02-24 | |
| 63539-284 | Ibrance | palbociclib | U.S. Pharmaceuticals | TABLET, FILM COATED | 2020-03-30 | |
| 63539-336 | CIBINQO | abrocitinib | U.S. Pharmaceuticals | TABLET, FILM COATED | 2022-02-24 | |
| 63539-436 | CIBINQO | abrocitinib | U.S. Pharmaceuticals | TABLET, FILM COATED | 2022-02-24 | |
| 63539-486 | Ibrance | palbociclib | U.S. Pharmaceuticals | TABLET, FILM COATED | 2020-03-30 | |
| 63539-688 | Ibrance | palbociclib | U.S. Pharmaceuticals | TABLET, FILM COATED | 2020-03-30 | |
| 63539-927 | Lorbrena | lorlatinib | U.S. Pharmaceuticals | TABLET, FILM COATED | 2023-01-03 | |
| 63850-0058 | Everolimus | Everolimus | Natco Pharma Limited | TABLET | 2021-03-05 | |
| 63850-0059 | Everolimus | Everolimus | Natco Pharma Limited | TABLET | 2021-03-05 | |
| 63850-0060 | Everolimus | Everolimus | Natco Pharma Limited | TABLET | 2021-03-05 | |
| 63850-0061 | Everolimus | Everolimus | Natco Pharma Limited | TABLET | 2021-10-01 | |
| 63850-0062 | Everolimus | Everolimus | Natco Pharma Limited | TABLET | 2021-05-20 | |
| 63850-0063 | Everolimus | Everolimus | Natco Pharma Limited | TABLET | 2021-05-20 | |
| 63850-0064 | Everolimus | Everolimus | Natco Pharma Limited | TABLET | 2021-05-20 | |
| 64764-800 | Livtencity | MARIBAVIR | Takeda Pharmaceuticals America, Inc. | TABLET, COATED | 2021-11-23 | |
| 64842-0120 | LYTGOBI | FUTIBATINIB | TAIHO PHARMACEUTICAL CO., LTD. | TABLET | 2023-02-03 | |
| 65841-771 | sirolimus | sirolimus | Zydus Lifesciences Limited | TABLET, FILM COATED | 2014-01-15 | |
| 65841-772 | sirolimus | sirolimus | Zydus Lifesciences Limited | TABLET, FILM COATED | 2023-02-16 | |
| 65841-773 | sirolimus | sirolimus | Zydus Lifesciences Limited | TABLET, FILM COATED | 2023-02-16 | |
| 66689-347 | Sirolimus | Sirolimus | VistaPharm, LLC | SOLUTION | 2019-01-28 | |
| 67184-0531 | Gefitinib | Gefitinib | Qilu Pharmaceutical Co., Ltd. | TABLET, COATED | 2023-02-13 | |
| 67877-718 | Everolimus | Everolimus | Ascend Laboratories, LLC | TABLET | 2021-11-27 | |
| 67877-719 | Everolimus | Everolimus | Ascend Laboratories, LLC | TABLET | 2021-11-27 | |
| 67877-720 | Everolimus | Everolimus | Ascend Laboratories, LLC | TABLET | 2021-11-27 | |
| 67877-721 | Everolimus | Everolimus | Ascend Laboratories, LLC | TABLET | 2021-11-27 | |
| 67877-746 | Sirolimus | Sirolimus | Ascend Laboratories, LLC | TABLET | 2021-03-13 | |
| 67877-747 | Sirolimus | Sirolimus | Ascend Laboratories, LLC | TABLET | 2021-03-13 | |
| 67877-748 | Sirolimus | Sirolimus | Ascend Laboratories, LLC | TABLET | 2021-03-13 | |
| 68084-915 | Sirolimus | Sirolimus | American Health Packaging | TABLET | 2015-11-05 | |
| 68382-351 | sirolimus | sirolimus | Zydus Pharmaceuticals USA Inc. | TABLET, FILM COATED | 2023-02-16 | |
| 68382-352 | sirolimus | sirolimus | Zydus Pharmaceuticals USA Inc. | TABLET, FILM COATED | 2023-02-16 | |
| 68382-520 | sirolimus | sirolimus | Zydus Pharmaceuticals USA Inc. | TABLET, FILM COATED | 2014-01-15 | |
| 68462-682 | sirolimus | sirolimus | Glenmark Pharmaceuticals Inc., USA | TABLET, FILM COATED | 2020-10-16 | |
| 68462-683 | sirolimus | sirolimus | Glenmark Pharmaceuticals Inc., USA | TABLET, FILM COATED | 2020-10-16 | |
| 68462-684 | sirolimus | sirolimus | Glenmark Pharmaceuticals Inc., USA | TABLET, FILM COATED | 2020-10-16 | |
| 69097-030 | Nilotinib | Nilotinib | Cipla USA Inc. | CAPSULE | 2025-06-18 | |
| 69097-031 | Nilotinib | Nilotinib | Cipla USA Inc. | CAPSULE | 2025-06-18 | |
| 69097-032 | Nilotinib | Nilotinib | Cipla USA Inc. | CAPSULE | 2025-06-18 | |
| 69238-1594 | Sirolimus | SIrolimus | Amneal Pharmaceuticals NY LLC | SOLUTION | 2019-10-25 | |
| 69339-168 | Gefitinib | Gefitinib | Natco Pharma USA LLC | TABLET, FILM COATED | 2023-06-05 | |
| 70377-010 | EVEROLIMUS | everolimus | Biocon Pharma Inc. | TABLET | 2021-10-01 | |
| 70377-011 | EVEROLIMUS | everolimus | Biocon Pharma Inc. | TABLET | 2021-10-01 | |
| 70377-012 | EVEROLIMUS | everolimus | Biocon Pharma Inc. | TABLET | 2021-10-01 | |
| 70377-013 | EVEROLIMUS | everolimus | Biocon Pharma Inc. | TABLET | 2021-10-01 | |
| 70377-069 | Everolimus | Everolimus | Biocon Pharma Inc. | TABLET | 2025-06-02 | |
| 70377-070 | Everolimus | EVEROLIMUS | Biocon Pharma Inc. | TABLET | 2025-06-02 | |
| 70377-071 | Everolimus | everolimus | Biocon Pharma Inc. | TABLET | 2025-06-02 | |
| 70377-112 | Everolimus | everolimus | Biocon Pharma Inc. | TABLET | 2025-06-02 | |
| 70518-3546 | Sirolimus | Sirolimus | REMEDYREPACK INC. | TABLET | 2022-09-30 | |
| 70518-4376 | sirolimus | sirolimus | REMEDYREPACK INC. | TABLET, FILM COATED | 2025-06-28 | |
| 70518-4449 | sirolimus | sirolimus | REMEDYREPACK INC. | TABLET, FILM COATED | 2025-08-19 | |
| 71332-006 | Gavreto | Pralsetinib | Rigel Pharmaceuticals, Inc. | CAPSULE | 2024-06-24 | |
| 71777-390 | VITRAKVI | LAROTRECTINIB | Loxo Oncology, Inc. | CAPSULE | 2018-11-26 | |
| 71777-391 | VITRAKVI | LAROTRECTINIB | Loxo Oncology, Inc. | CAPSULE | 2018-11-26 | |
| 71777-392 | VITRAKVI | LAROTRECTINIB | Loxo Oncology, Inc. | SOLUTION | 2018-11-26 | |
| 72064-110 | Ayvakit | avapritinib | Blueprint Medicines Corporation | TABLET, FILM COATED | 2020-01-09 | |
| 72064-120 | Ayvakit | avapritinib | Blueprint Medicines Corporation | TABLET, FILM COATED | 2020-01-09 | |
| 72064-125 | Ayvakit | avapritinib | Blueprint Medicines Corporation | TABLET, FILM COATED | 2021-06-16 | |
| 72064-130 | Ayvakit | avapritinib | Blueprint Medicines Corporation | TABLET, FILM COATED | 2020-01-09 | |
| 72064-150 | Ayvakit | avapritinib | Blueprint Medicines Corporation | TABLET, FILM COATED | 2021-06-16 | |
| 72205-099 | sirolimus | sirolimus | Novadoz Pharmaceuticals LLC | SOLUTION | 2023-01-19 | |
| 72482-100 | Vonjo | Pacritinib | Sobi, Inc. | CAPSULE | 2022-02-28 | |
| 72579-011 | BRUKINSA | zanubrutinib | BeOne Medicines USA, Inc. | CAPSULE | 2019-11-14 | |
| 72579-122 | BRUKINSA | zanubrutinib | BeOne Medicines USA, Inc. | TABLET, FILM COATED | 2025-08-18 | |
| 72603-254 | EVEROLIMUS | everolimus | NorthStar RxLLC | TABLET | 2024-10-01 | |
| 72603-255 | EVEROLIMUS | everolimus | NorthStar RxLLC | TABLET | 2024-10-01 | |
| 72603-256 | EVEROLIMUS | everolimus | NorthStar RxLLC | TABLET | 2024-10-01 | |
| 72603-257 | EVEROLIMUS | everolimus | NorthStar RxLLC | TABLET | 2024-10-01 | |
| 72603-409 | sirolimus | sirolimus | Northstar Rx LLC | SOLUTION | 2023-01-19 | |
| 73207-101 | QINLOCK | Ripretinib | Deciphera Pharmaceuticals, LLC | TABLET | 2020-05-15 | |
| 73207-302 | ROMVIMZA | Vimseltinib | Deciphera Pharmaceuticals, LLC | CAPSULE | 2025-02-14 | |
| 73207-303 | ROMVIMZA | Vimseltinib | Deciphera Pharmaceuticals, LLC | CAPSULE | 2025-02-14 | |
| 73207-304 | ROMVIMZA | Vimseltinib | Deciphera Pharmaceuticals, LLC | CAPSULE | 2025-02-14 | |
| 73683-101 | HYFTOR | sirolimus | Nobelpharma America, LLC | GEL | 2022-03-23 | |
| 80803-153 | FYARRO | Sirolimus | Aadi Bioscience | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION | 2021-12-06 | |
| 82448-130 | Gomekli | mirdametinib | SpringWorks Therapeutics, Inc. | CAPSULE | 2025-02-11 | |
| 82448-134 | Gomekli | mirdametinib | SpringWorks Therapeutics, Inc. | TABLET, FOR SUSPENSION | 2025-02-11 | |
| 82448-260 | Gomekli | mirdametinib | SpringWorks Therapeutics, Inc. | CAPSULE | 2025-02-11 | |
| 82950-001 | OJEMDA | TOVORAFENIB | Day One Biopharmaceuticals, Inc. | TABLET, FILM COATED | 2024-04-30 | |
| 82950-012 | OJEMDA | tovorafenib | Day One Biopharmaceuticals, Inc. | KIT | 2024-04-30 |
Loading full table content...